Savant Capital LLC Invests $243,000 in Adient $ADNT

Savant Capital LLC acquired a new stake in Adient (NYSE:ADNT) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 12,471 shares of the company’s stock, valued at approximately $243,000.

A number of other hedge funds have also recently bought and sold shares of ADNT. Brooklyn Investment Group raised its holdings in Adient by 23,600.0% in the 1st quarter. Brooklyn Investment Group now owns 2,133 shares of the company’s stock valued at $27,000 after acquiring an additional 2,124 shares during the last quarter. Fifth Third Bancorp grew its position in shares of Adient by 544.4% in the second quarter. Fifth Third Bancorp now owns 2,133 shares of the company’s stock valued at $42,000 after purchasing an additional 1,802 shares during the period. MassMutual Private Wealth & Trust FSB increased its stake in Adient by 991.0% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 2,182 shares of the company’s stock valued at $42,000 after purchasing an additional 1,982 shares during the last quarter. Parallel Advisors LLC lifted its position in Adient by 13,957.9% during the second quarter. Parallel Advisors LLC now owns 2,671 shares of the company’s stock worth $52,000 after buying an additional 2,652 shares during the period. Finally, CWM LLC boosted its stake in Adient by 91.4% in the 1st quarter. CWM LLC now owns 3,426 shares of the company’s stock worth $44,000 after buying an additional 1,636 shares during the last quarter. Institutional investors and hedge funds own 92.44% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on ADNT shares. Cfra Research raised shares of Adient from a “moderate sell” rating to a “hold” rating in a research note on Thursday, August 7th. Bank of America upped their price target on shares of Adient from $17.50 to $20.00 and gave the stock an “underperform” rating in a research report on Wednesday, September 10th. Weiss Ratings reiterated a “sell (d)” rating on shares of Adient in a report on Wednesday, October 8th. Barclays lowered their price objective on shares of Adient from $27.00 to $24.00 and set an “equal weight” rating for the company in a research note on Friday, November 7th. Finally, UBS Group cut their target price on Adient from $28.00 to $22.00 and set a “neutral” rating on the stock in a research report on Thursday, November 6th. Two investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, Adient presently has a consensus rating of “Reduce” and an average price target of $22.69.

Adient Stock Performance

NYSE:ADNT opened at $18.79 on Thursday. The firm’s fifty day simple moving average is $23.07 and its 200 day simple moving average is $21.20. The company has a current ratio of 1.12, a quick ratio of 0.93 and a debt-to-equity ratio of 1.16. Adient has a twelve month low of $10.04 and a twelve month high of $26.16. The firm has a market capitalization of $1.53 billion, a price-to-earnings ratio of -5.62, a PEG ratio of 0.61 and a beta of 1.87.

Adient (NYSE:ADNT) last released its quarterly earnings data on Wednesday, May 31st. The company reported ($0.13) EPS for the quarter. Adient had a negative net margin of 1.93% and a positive return on equity of 7.81%. The company had revenue of $3.51 billion during the quarter. As a group, equities research analysts expect that Adient will post 1.76 earnings per share for the current fiscal year.

About Adient

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.